Cigna Historical Cash Flow
| CI Stock | USD 339.26 4.02 1.17% |
Analysis of Cigna Corp cash flow over time is an excellent tool to project Cigna Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 10.8 B or Change In Working Capital of 3.7 B as it is a great indicator of Cigna Corp ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Cigna Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cigna Corp is a good buy for the upcoming year.
Cigna |
About Cigna Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Cigna balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cigna's non-liquid assets can be easily converted into cash.
Cigna Corp Cash Flow Chart
Cigna Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Cigna Corp Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
As of now, Cigna Corp's Begin Period Cash Flow is increasing as compared to previous years. The Cigna Corp's current Capital Expenditures is estimated to increase to about 1.7 B, while Sale Purchase Of Stock is projected to decrease to (2.4 B). Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Cigna Corp financial statement analysis. It represents the amount of money remaining after all of Cigna Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Cigna Corp's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Cigna Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cigna Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.As of now, Cigna Corp's Begin Period Cash Flow is increasing as compared to previous years. The Cigna Corp's current Capital Expenditures is estimated to increase to about 1.7 B, while Sale Purchase Of Stock is projected to decrease to (2.4 B).
Cigna Corp cash flow statement Correlations
Click cells to compare fundamentals
Cigna Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cigna Corp cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (2.0B) | (4.0B) | (7.7B) | (7.6B) | (2.3B) | (2.4B) | |
| Change In Cash | 1.6B | 4.8B | (4.7B) | 428M | 1.9B | 2.0B | |
| Free Cash Flow | 8.4B | 9.3B | 6.0B | 7.4B | 10.2B | 10.8B | |
| Change In Working Capital | 643M | 3.6B | (872M) | 620M | 3.5B | 3.7B | |
| Begin Period Cash Flow | 3.9B | 5.4B | 10.2B | 5.5B | 5.9B | 6.2B | |
| Other Cashflows From Financing Activities | (252M) | 9.5B | 5.1B | (2.1B) | (469M) | (445.6M) | |
| Other Non Cash Items | 561M | 199M | 141M | (1.4B) | (7.7B) | (7.3B) | |
| Dividends Paid | 681M | (15M) | (1.3B) | (1.4B) | (1.5B) | (1.4B) | |
| Capital Expenditures | 1.1B | 1.1B | 1.2B | 1.3B | 1.6B | 1.7B | |
| Total Cash From Operating Activities | 9.5B | 10.4B | 7.2B | 8.7B | 11.8B | 12.4B | |
| Change To Account Receivables | (990M) | (1.3B) | (3.2B) | (2.3B) | (2.2B) | (2.1B) | |
| Net Income | 5.1B | 8.5B | 5.4B | 6.7B | 5.2B | 5.4B | |
| Total Cash From Financing Activities | (7.2B) | (8.5B) | (8.2B) | (11.2B) | (4.3B) | (4.1B) | |
| End Period Cash Flow | 5.4B | 10.2B | 5.5B | 6.0B | 7.8B | 8.2B | |
| Depreciation | 3.7B | 2.8B | 2.9B | 2.9B | 3.0B | 3.2B | |
| Stock Based Compensation | 299M | 289M | 268M | 264M | 286M | 175.2M | |
| Other Cashflows From Investing Activities | 5.1B | 3.4B | (3.6B) | 4.4B | 4.0B | 4.2B | |
| Total Cashflows From Investing Activities | (734M) | 3.0B | (3.6B) | 3.1B | 2.8B | 2.9B | |
| Change To Netincome | (488M) | (4.5B) | (225M) | (1.6B) | (1.5B) | (1.4B) | |
| Investments | (4.8B) | (443M) | (765M) | (587M) | (5.2B) | (4.9B) | |
| Net Borrowings | (5.2B) | (4.8B) | 800M | (500M) | (450M) | (427.5M) | |
| Change To Operating Activities | (136M) | 4.3B | 2.6B | 2.3B | 2.7B | 2.8B | |
| Change To Liabilities | 1.9B | 2.2B | (77M) | 1.9B | 2.1B | 2.3B | |
| Change Receivables | (990M) | (1.3B) | (3.2B) | (2.3B) | (2.0B) | (2.1B) | |
| Cash And Cash Equivalents Changes | 1.6B | 4.8B | (4.6B) | 514M | 462.6M | 499.5M | |
| Cash Flows Other Operating | 125M | 3.2B | 2.0B | 2.1B | 2.4B | 1.5B | |
| Issuance Of Capital Stock | 224M | 376M | 326M | 389M | 185M | 287.5M |
Currently Active Assets on Macroaxis
When determining whether Cigna Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cigna Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cigna Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cigna Corp Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cigna Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Cigna Stock analysis
When running Cigna Corp's price analysis, check to measure Cigna Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cigna Corp is operating at the current time. Most of Cigna Corp's value examination focuses on studying past and present price action to predict the probability of Cigna Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cigna Corp's price. Additionally, you may evaluate how the addition of Cigna Corp to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Cigna Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cigna Corp. If investors know Cigna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cigna Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.10) | Dividend Share 5.09 | Earnings Share 12.19 | Revenue Per Share 700.13 | Quarterly Revenue Growth 0.193 |
The market value of Cigna Corp is measured differently than its book value, which is the value of Cigna that is recorded on the company's balance sheet. Investors also form their own opinion of Cigna Corp's value that differs from its market value or its book value, called intrinsic value, which is Cigna Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cigna Corp's market value can be influenced by many factors that don't directly affect Cigna Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cigna Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cigna Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cigna Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.